Risk factors for heart transplant survival with greater than 5 h of donor heart ischemic time
- PMID: 34018246
- PMCID: PMC11175709
- DOI: 10.1111/jocs.15621
Risk factors for heart transplant survival with greater than 5 h of donor heart ischemic time
Abstract
Objective: Implantation of donor hearts with prolonged ischemic times is associated with worse survival. We sought to identify risk factors that modulate the effects of prolonged preservation.
Methods: Retrospective review of the United Network for Organ Sharing database (2000-2018) to identify transplants with >5 (n = 1526) or ≤5 h (n = 35,733) of donor heart preservation. In transplanted hearts preserved for >5 h, Cox-proportional hazards identify modifiers for survival.
Results: Compared to ≤5 h, transplanted patients with >5 h of preservation spent less time in status 1B (76 ± 160 vs. 85 ± 173 days, p = .027), more commonly had ischemic cardiomyopathy (42.3% vs. 38.3%, p = .002), and less commonly received a blood type O heart (45.4% vs. 50.8%, p < .001). Longer heart preservation time was associated with a higher incidence of postoperative stroke (4.5% vs. 2.5%, p < .001), and dialysis (16.4% vs. 10.6%, p < .001). Prolonged preservation was associated with a greater likelihood of death from primary graft dysfunction (2.8% vs. 1.5%, p < .001) but there was no difference in death from acute (2.0% vs. 1.7%, p = .402) or chronic rejection (2.0% vs. 1.9%, p = .618). In transplanted patients with >5 h of heart preservation, multivariable analysis identified greater mortality with ischemic cardiomyopathy etiology (hazard ratio [HR] = 1.36, p < 0.01), pre-transplant dialysis (HR = 1.84, p < .01), pre-transplant extracorporeal membrane oxygenation (ECMO, HR = 2.36, p = .09), and O blood type donor hearts (HR = 1.35, p < .01).
Conclusion: Preservation time >5 h is associated with worse survival. This mortality risk is further amplified by preoperative dialysis and ECMO, ischemic cardiomyopathy etiology, and use of O blood type donor hearts.
Keywords: heart transplant; ischemia/reperfusion injury; outcomes; primary graft dysfunction.
© 2021 Wiley Periodicals LLC.
Conflict of interest statement
CONFLICT OF INTERESTS
The authors declare that there are no conflict of interests.
Figures


Comment in
-
Risk factors for heart transplant survival with greater than 5 h of donor heart ischemic time.J Card Surg. 2022 Nov;37(11):4013. doi: 10.1111/jocs.16906. Epub 2022 Sep 4. J Card Surg. 2022. PMID: 36057981 No abstract available.
Similar articles
-
Determining optimal donor heart ischemic times in adult cardiac transplantation.J Card Surg. 2022 Jul;37(7):2042-2050. doi: 10.1111/jocs.16558. Epub 2022 Apr 30. J Card Surg. 2022. PMID: 35488767 Free PMC article.
-
Impact of donor blood type on outcomes after prolonged allograft ischemic times.J Thorac Cardiovasc Surg. 2022 Sep;164(3):981-993.e8. doi: 10.1016/j.jtcvs.2020.12.123. Epub 2021 Jan 12. J Thorac Cardiovasc Surg. 2022. PMID: 33558115 Free PMC article.
-
Impact of using higher-risk donor hearts for candidates with pre-transplant mechanical circulatory support.J Heart Lung Transplant. 2022 Feb;41(2):237-243. doi: 10.1016/j.healun.2021.09.016. Epub 2021 Oct 22. J Heart Lung Transplant. 2022. PMID: 34815161
-
Determinants of survival following heart transplantation in adults with congenital heart disease.J Cardiothorac Surg. 2024 Feb 10;19(1):83. doi: 10.1186/s13019-024-02509-0. J Cardiothorac Surg. 2024. PMID: 38336724 Free PMC article. Review.
-
Portable Normothermic Cardiac Perfusion System in Donation After Cardiocirculatory Death: A Health Technology Assessment.Ont Health Technol Assess Ser. 2020 Mar 6;20(3):1-90. eCollection 2020. Ont Health Technol Assess Ser. 2020. PMID: 32190164 Free PMC article.
Cited by
-
Response to letter by Miyauchi et al.J Card Surg. 2021 Oct;36(10):3987-3988. doi: 10.1111/jocs.15790. Epub 2021 Jul 7. J Card Surg. 2021. PMID: 34232522 Free PMC article. No abstract available.
-
A letter to the editor in response to "Association between vasoactive-inotropic score, morbidity and mortality after heart transplantation".Interdiscip Cardiovasc Thorac Surg. 2023 Jul 19;37(1):ivad118. doi: 10.1093/icvts/ivad118. Interdiscip Cardiovasc Thorac Surg. 2023. PMID: 37449899 Free PMC article. No abstract available.
-
Heart transplantation: comparing the impact of modified heart preservation with conventional methods.Sci Rep. 2025 Jan 23;15(1):2937. doi: 10.1038/s41598-025-87091-8. Sci Rep. 2025. PMID: 39849092 Free PMC article.
-
The effect of donor distance on post-transplant mortality in the modern era.JTCVS Open. 2025 Mar 10;25:241-252. doi: 10.1016/j.xjon.2025.02.019. eCollection 2025 Jun. JTCVS Open. 2025. PMID: 40631029 Free PMC article.
-
Heart Transplant Rejection: From the Endomyocardial Biopsy to Gene Expression Profiling.Biomedicines. 2024 Aug 22;12(8):1926. doi: 10.3390/biomedicines12081926. Biomedicines. 2024. PMID: 39200392 Free PMC article. Review.
References
-
- John R Donor management and selection for heart transplantation. Semin Thorac Cardiovasc Surg. 2004;16(4):364–369. - PubMed
-
- Del Rizzo DF, Menkis AH, Pflugfelder PW, et al. The role of donor age and ischemic time on survival following orthotopic heart transplantation. J Heart Lung Transplant. 1999;18(4):310–319. - PubMed
-
- Cogswell R, John R, Estep JD, et al. An early investigation of outcomes with the new 2018 donor heart allocation system in the United States. J Heart Lung Transplant. 2020;39(1):1–4. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical